WO2005117859A3 - Diagnostic d'affection cardiovasculaire - Google Patents
Diagnostic d'affection cardiovasculaire Download PDFInfo
- Publication number
- WO2005117859A3 WO2005117859A3 PCT/US2005/016370 US2005016370W WO2005117859A3 WO 2005117859 A3 WO2005117859 A3 WO 2005117859A3 US 2005016370 W US2005016370 W US 2005016370W WO 2005117859 A3 WO2005117859 A3 WO 2005117859A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- cardiovascular disease
- diagnosing cardiovascular
- diagnosing
- subject
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Abstract
Ces procédés visent à diagnostiquer un patient aux risques accrus d'affection cardiovasculaire.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/248,578 US8080374B2 (en) | 2004-05-11 | 2005-10-12 | Methods of diagnosing cardiovascular disease |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56989804P | 2004-05-11 | 2004-05-11 | |
| US60/569,898 | 2004-05-11 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/248,578 Continuation-In-Part US8080374B2 (en) | 2004-05-11 | 2005-10-12 | Methods of diagnosing cardiovascular disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2005117859A2 WO2005117859A2 (fr) | 2005-12-15 |
| WO2005117859A3 true WO2005117859A3 (fr) | 2006-04-20 |
Family
ID=35463320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2005/016370 WO2005117859A2 (fr) | 2004-05-11 | 2005-05-10 | Diagnostic d'affection cardiovasculaire |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2005117859A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008213472A1 (en) * | 2007-02-05 | 2008-08-14 | Aarhus Universitet | A method for diagnosing atherosclerotic plaques by measurement of CD36 |
| WO2009128734A1 (fr) * | 2008-04-18 | 2009-10-22 | Vialactia Biosciences (Nz) Limited | Identification assistée par un marqueur de mammifères ayant un caractère phénotypique souhaité |
-
2005
- 2005-05-10 WO PCT/US2005/016370 patent/WO2005117859A2/fr active Application Filing
Non-Patent Citations (3)
| Title |
|---|
| HANAWA H. ET AL: "Identification of Cryptic Splice Site, Exon Skipping, and Novel Point Mutations in type I CD36 Deficiency", JOURNAL OF MEDICAL GENETICS, vol. 39, no. 4, April 2002 (2002-04-01), pages 286 - 291, XP002995099 * |
| MA X. ET AL: "Common Haplotype At The CD36 Locus Is Associated With High Free Fatty Acid Levels And Increased Cardiovascular Risk In Caucasians", HUMAN MOLECULAR GENETICS, vol. 13, no. 19, October 2004 (2004-10-01), pages 2197 - 2205, XP002995100 * |
| TANAKA T. ET AL: "Defect in Human Myocardial Long-Chain Fatty Acid Uptake Is Caused by FAT/CD36 mutations", JOURNAL OF LIPID RESEARCH, vol. 42, no. 5, May 2001 (2001-05-01), pages 751 - 759, XP002995098 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005117859A2 (fr) | 2005-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0401730D0 (en) | Diagnosis method | |
| GB2414190B (en) | Golf swing diagnosing system | |
| GB2415834B (en) | Completion assemblies. | |
| EP1806581A4 (fr) | Systeme de diagnostic d'une maladie | |
| HK1114171A1 (en) | Copeptin-based diagnostic kit for disorders | |
| EP1787116A4 (fr) | Procedes d'evaluation des risques de developpement de maladies cardio-vasculaires | |
| WO2007061906A3 (fr) | Diagnostic et moyens therapeutiques pour troubles cardio-vasculaires | |
| IL181507A0 (en) | Methods for making retinoids and uses thereof | |
| WO2007106466A3 (fr) | Bêta-2 microglobuline utilisée comme biomarqueur pour des maladies artérielles périphériques | |
| GB0518925D0 (en) | Decking, kit of parts for making decking, and method of assembling the decking | |
| WO2005117859A3 (fr) | Diagnostic d'affection cardiovasculaire | |
| WO2007038155A3 (fr) | Methodes de diagnostic d'une maladie cardiovasculaire | |
| WO2006136928A8 (fr) | Techniques non invasives de determination de l'etat cardio-vasculaire d'une personne | |
| GB0408684D0 (en) | Diagnostic method | |
| AP2005003355A0 (en) | Beverage kit and method for producing a non-fermented malt-beverage. | |
| GB0423329D0 (en) | Double ender | |
| GB0413918D0 (en) | Diagnostic method | |
| GB0421257D0 (en) | Diagnostic method | |
| GB0408685D0 (en) | Diagnostic method | |
| GB0413914D0 (en) | Diagnostic method | |
| GB0400607D0 (en) | Diagnostic method | |
| GB0421258D0 (en) | Diagnostic method | |
| GB0413917D0 (en) | Diagnostic method | |
| GB0413915D0 (en) | Diagnostic method | |
| GB0413916D0 (en) | Diagnostic method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 11248578 Country of ref document: US |
|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWP | Wipo information: published in national office |
Ref document number: 11248578 Country of ref document: US |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
| 122 | Ep: pct application non-entry in european phase |